ArticleFrontiers in pharmacology2025
1-stearoyl-2-arachidonoyl-driven B Cell metabolic dysregulation in chronic rhinosinusitis with nasal polyps: insights from Mendelian randomization and single-cell RNA sequencing.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP), an inflammatory condition of unclear etiology, may involve immune dysregulation and metabolic alterations. Methods: Utilizing Mendelian randomization, we investigated causal links between CRSwNP and profiles of 731 immune cell types and 1,400 metabolites. Single-cell RNA sequencing (scRNA-seq) was employed for cell type identification and transcription factor analysis. Metabolic profiling characterized cellular subpopulations, while Gene Set Enrichment Analysis (GSEA) and machine learning pinpointed key genes functionally linked to immune and inflammatory pathways (categorized via WGCNA and Metascape). Results: We identified expression of HLA-DR on CD33- HLA-DR + B cells and the lipid metabolite 1-stearoyl-2-arachidonoyl as risk factors for CRSwNP. scRNA-seq further revealed these specific B cell subpopulations exhibit metabolic levels linked to immune responses. Bulk RNA analysis confirmed upregulation of genes CD27 and DERL3, while machine learning identified a signature of ten key genes showing positive correlation with B cell regulatory functions. Conclusion: This integrated study advances understanding of immune-metabolic crosstalk in CRSwNP pathogenesis, highlighting the role of metabolite-influenced B cell subsets in shaping the immune microenvironment, thereby suggesting novel therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.